Onsdag 29 Oktober | 11:59:17 Europe / Stockholm

Prenumeration

2025-10-27 14:13:00

Redeye provides an update following Iconovo’s Q3 report. The report was relatively uneventful, and we emphasise that tangible progress in Iconovo’s larger projects will be crucial for the share to rerate. We have revised our sales and OPEX estimates in this update, resulting in an updated fair value range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/